[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.173.253. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 8, 1966

Histiocytosis X: Response to Vinblastine Sulfate

Author Affiliations

USAF; USAF

From the Department of Medicine, Wilford Hall USAF Hospital, Aerospace Medical Division (AFSC), Lackland Air Force Base, Tex.; Reprint requests to Department of Medicine, Wilford Hall USAF Hospital, Aerospace Medical Division (AFSC), Lackland Air Force Base, Tex 78236 (Capt Siegel).

JAMA. 1966;197(6):403-406. doi:10.1001/jama.1966.03110060077019
Abstract

The designation histiocytosis X was coined as a unifying diagnostic term by Lichtenstein to draw attention to the pathological unity made up of several diverse and transitional syndromes, ie, eosinophilic xanthomatous granuloma, Hand-Schüller-Christian syndrome and Letterer-Siwe disease. Lichtenstein preferred the terms localized, chronic disseminated, and acute disseminated histiocytosis X to represent these related entities. A 40-year-old white man presented with localized histiocytosis X which progressed to a chronic disseminated form of the disease that could not be distinguished from Hand-Schüller-Christian disease. Almost complete resolution of this very resistant tumor occurred following treatment with vinblastine sulfate.

×